Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.04%1.15B | -6.98%700.73M | 2.59%309.99M | 5.01%1.68B | 15.22%1.26B | 26.75%753.31M | 54.35%302.15M | 49.94%1.6B | 35.73%1.09B | 28.32%594.33M |
| Operating revenue | -9.04%1.15B | -6.98%700.73M | 2.59%309.99M | 5.01%1.68B | 15.22%1.26B | 26.75%753.31M | 54.35%302.15M | 49.94%1.6B | 35.73%1.09B | 28.32%594.33M |
| Other operating revenue | ---- | -23.84%2.28M | ---- | -36.10%6.9M | ---- | 40.77%2.99M | ---- | -53.63%10.8M | ---- | -2.14%2.13M |
| Total operating cost | -8.02%1.11B | -4.76%687.92M | 7.04%312.85M | 1.29%1.63B | 8.32%1.21B | 16.10%722.32M | 39.84%292.26M | 41.86%1.61B | 30.84%1.12B | 25.57%622.13M |
| Operating cost | -9.12%1.04B | -5.98%640.06M | 6.54%291.49M | 0.63%1.53B | 7.75%1.14B | 15.90%680.79M | 41.29%273.6M | 44.99%1.52B | 34.89%1.06B | 31.11%587.4M |
| Operating tax surcharges | 16.94%3.42M | 27.27%2.44M | 41.89%1.31M | 2.61%3.89M | 4.51%2.92M | 6.14%1.91M | 9.40%922.48K | 13.96%3.79M | 14.14%2.79M | 16.38%1.8M |
| Operating expense | 3.96%5.82M | 7.26%3.78M | 11.92%1.75M | 8.91%7.78M | 14.68%5.6M | 21.09%3.53M | 7.92%1.57M | 37.94%7.14M | -5.71%4.88M | -11.18%2.91M |
| Administration expense | 7.88%24.42M | 13.25%16.11M | 17.92%7.52M | 32.96%37.26M | 14.18%22.63M | 9.05%14.23M | 1.75%6.38M | -11.03%28.02M | -22.42%19.82M | -30.81%13.05M |
| Financial expense | 79.39%-900.3K | 83.78%-657.64K | 61.85%-374.75K | -52.97%-4.68M | -72.77%-4.37M | -121.39%-4.05M | 12.30%-982.2K | -12.09%-3.06M | -27.43%-2.53M | -43.17%-1.83M |
| -Interest Income (Financial expense) | 79.09%-919.56K | 83.48%-672.24K | 61.11%-385.41K | -50.83%-4.73M | -69.96%-4.4M | -117.93%-4.07M | 12.69%-991.08K | -8.36%-3.13M | -21.67%-2.59M | -36.46%-1.87M |
| Research and development | 2.96%42.3M | 1.09%26.19M | 3.53%11.15M | 5.42%53.25M | 27.93%41.08M | 37.82%25.91M | 36.33%10.77M | 7.88%50.51M | -12.57%32.11M | -24.93%18.8M |
| Credit Impairment Loss | 210.03%135.04K | 253.45%148.13K | 180.72%135.89K | 344.18%134.59K | 35.08%-122.73K | 56.01%-96.53K | -55.69%-168.35K | 52.13%-55.12K | -114.92%-189.06K | -66.71%-219.45K |
| Asset Impairment Loss | -103.21%-5.7M | 57.92%-594.25K | -14.66%-496.66K | -278.71%-12.46M | -7.99%-2.8M | 80.79%-1.41M | 93.71%-433.17K | 81.87%-3.29M | 79.78%-2.6M | -42.84%-7.35M |
| Other net revenue | 94.02%26.3M | 367.03%21.69M | 395.51%16.32M | -51.29%9.41M | 66.94%13.56M | 886.36%4.64M | 216.49%3.29M | 3,409.08%19.33M | 1,211.36%8.12M | -88.63%470.75K |
| Fair value change income | 99.52%2.33M | 58.88%1.76M | 70.56%1.4M | -0.11%1.6M | -58.41%1.17M | -55.97%1.11M | -37.13%819.95K | -5.72%1.6M | --2.81M | --2.51M |
| Invest income | 34.83%6.22M | 18.73%3.4M | -21.51%1.26M | -40.73%6.65M | -37.03%4.61M | -40.75%2.86M | -43.02%1.6M | -32.22%11.23M | -37.60%7.33M | -46.45%4.83M |
| Asset deal income | -101.49%-15.21K | -99.35%6.62K | -99.35%6.62K | 3,295.72%1.02M | 3,291.79%1.02M | 18,569.83%1.02M | --1.02M | 204.65%30.05K | 204.65%30.05K | 119.01%5.46K |
| Other revenue | 140.95%23.33M | 1,357.91%16.97M | 3,004.70%14.02M | 27.05%12.47M | 1,214.36%9.68M | 67.81%1.16M | 776.94%451.47K | 1,568.89%9.81M | 49.62%736.58K | 64.88%693.58K |
| Operating profit | -6.49%58.64M | -3.21%34.49M | 2.11%13.47M | 488.18%59.53M | 488.55%62.71M | 230.43%35.64M | 182.14%13.19M | 115.18%10.12M | 67.27%-16.14M | 2.94%-27.32M |
| Add:Non operating Income | 74.86%67.55K | 2.27%28.26K | -20.94%12.25K | -61.03%51.28K | 25.64%38.63K | 31.70%27.63K | 358.46%15.5K | 35.33%131.6K | -65.42%30.75K | -71.49%20.98K |
| Less:Non operating expense | 3.26%51.74K | ---- | ---- | -59.35%50.11K | -59.35%50.11K | --105.32 | ---- | -58.29%123.25K | -50.70%123.25K | ---- |
| Total profit | -6.45%58.66M | -3.21%34.52M | 2.08%13.48M | 487.71%59.53M | 486.27%62.7M | 230.63%35.67M | 182.25%13.21M | 115.15%10.13M | 67.19%-16.23M | 2.76%-27.3M |
| Less:Income tax cost | -10.67%4.07M | -75.12%1.27M | -2.48%362.52K | 141.63%1.77M | 290.59%4.56M | 225.63%5.11M | 110.42%371.72K | 74.21%-4.25M | 67.56%-2.39M | 2.98%-4.07M |
| Net profit | -6.12%54.59M | 8.81%33.25M | 2.21%13.12M | 301.73%57.76M | 520.05%58.15M | 231.50%30.56M | 202.76%12.83M | 128.53%14.38M | 67.13%-13.84M | 2.72%-23.24M |
| Net profit from continuing operation | -6.12%54.59M | 8.81%33.25M | 2.21%13.12M | 301.73%57.76M | 520.05%58.15M | 231.50%30.56M | 202.76%12.83M | 128.53%14.38M | 67.13%-13.84M | 2.72%-23.24M |
| Net profit of parent company owners | -6.12%54.59M | 8.81%33.25M | 2.21%13.12M | 301.73%57.76M | 520.05%58.15M | 231.50%30.56M | 202.76%12.83M | 128.53%14.38M | 67.13%-13.84M | 2.72%-23.24M |
| Earning per share | ||||||||||
| Basic earning per share | -3.70%0.26 | 14.29%0.16 | 0.00%0.06 | 285.71%0.27 | 550.00%0.27 | 227.27%0.14 | 200.00%0.06 | 130.43%0.07 | 68.42%-0.06 | 21.43%-0.11 |
| Diluted earning per share | -7.41%0.25 | 7.14%0.15 | 0.00%0.06 | 285.71%0.27 | 550.00%0.27 | 227.27%0.14 | 200.00%0.06 | 130.43%0.07 | 68.42%-0.06 | 21.43%-0.11 |
| Other composite income | ||||||||||
| Total composite income | -6.12%54.59M | 8.81%33.25M | 2.21%13.12M | 301.73%57.76M | 520.05%58.15M | 231.50%30.56M | 202.76%12.83M | 128.53%14.38M | 67.13%-13.84M | 2.72%-23.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.